2015
DOI: 10.1146/annurev-bioeng-071114-040538
|View full text |Cite
|
Sign up to set email alerts
|

Microfluidic Sample Preparation for Medical Diagnostics

Abstract: Fast and reliable diagnoses are invaluable in clinical care. Samples (e.g., blood, urine, and saliva) are collected and analyzed for various biomarkers to quickly and sensitively assess disease progression, monitor response to treatment, and determine a patient's prognosis. Processing conventional samples entails many manual time-consuming steps. Consequently, clinical specimens must be processed by skilled technicians before antigens or nucleic acids are detected, and these are often present at dilute concent… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
78
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 111 publications
(78 citation statements)
references
References 89 publications
0
78
0
Order By: Relevance
“…The technical requirements of preanalytical procedures to extract and concentrate a biomarker prevent many in-development tests, most notably NATs, 29,31 from being implemented into POC clinical settings. Existing preanalytical procedures are also a major source of errors in laboratory diagnostics.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The technical requirements of preanalytical procedures to extract and concentrate a biomarker prevent many in-development tests, most notably NATs, 29,31 from being implemented into POC clinical settings. Existing preanalytical procedures are also a major source of errors in laboratory diagnostics.…”
Section: Discussionmentioning
confidence: 99%
“…Commercialized paper-based sample collection and plasma separation technologies are commonly used for sample collection. 27 Novel approaches to sample preparation, including microfluidic separation techniques 28,29 and extraction and concentration techniques, 29 have been previously reviewed. However, challenges remain before unprocessed blood or other clinical samples can be applied directly to amplification and detection assays at the POC.…”
Section: Diagnostic Formatmentioning
confidence: 99%
“…This enhances the bio-recognition occurring at the bio-receptor's surface because pre-treatment of the sample reduces the risk of non-specific interaction and also reduces the presence of unwanted large size particles which shield the bioreceptor. Although research is ongoing in the field of integrated sample preparation devices [15], human manipulation is still often required. This is one of the main reasons which explains that only a few number of devices developed using the bottom-up approach leads to actual medical devices which can be used in clinical environment.…”
Section: Researcher Point Of View: the Bottom-up Approachmentioning
confidence: 99%
“…[38][39][40][41] On-chip polymerized monolith-based SPE has been evaluated considerably for this purpose, primarily due to strong synergy with the mature liquid chromatography field. 38,39 Porous polymer monolith stationary phases form the basis of this sample preparation approach.…”
Section: On-chip Solid Phase Extraction and Separationmentioning
confidence: 99%